date,title,source
Oct-18-18,"Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-26-18,"Advaxis to Host Business Update Conference Call on November 2, 2018",Business Wire
Nov-06-18,Advaxis to Present Poster Entitled Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy at Society for Immunotherapy of Cancer Annual Meeting,Business Wire
Nov-28-18,Advaxis to Present at LD Micro Main Event,Business Wire
Dec-12-18,Will Advaxis (ADXS) Report Negative Earnings Next Week? What You Should Know,Zacks
Dec-12-18,"Could Advaxis, Inc.s (NASDAQ:ADXS) Investor Composition Influence The Stock Price?",Simply Wall St.
Jan-08-19,"Advaxis to Host Business Update Conference Call on January 15, 2019",Business Wire
Jan-10-19,"Advaxis (ADXS) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Jan-10-19,Advaxis Reports Fiscal Year 2018 Financial Results and Provides a Business Update,Business Wire
Jan-11-19,"The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA",Benzinga
Jan-18-19,Edited Transcript of ADXS earnings conference call or presentation 15-Jan-19 4:00pm GMT,Thomson Reuters StreetEvents
Jan-23-19,Advaxis Phase 3 AIM2CERV Study Placed on Partial Clinical Hold by FDA Related to CMC Requests,Business Wire
Jan-24-19,"Immunomodulation Bolsters Scientific Advisory Board with Appointments of Robert G. Petit, Ph.D. and Rex Chin-Wei Yung, M.D., F.C.C.P.",GlobeNewswire
Jan-24-19,"The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial",Benzinga
Jan-25-19,Data Highlighting Potential Benefits of Lm Platform Presented at 2019 Keystone Symposia Conference on Cancer Vaccines,Business Wire
Jan-30-19,"New Research Coverage Highlights Heron Therapeutics, IDACORP, Star Bulk Carriers, AngioDynamics, Marinus Pharmaceuticals, and Advaxis  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Jan-31-19,Edited Transcript of ADXS earnings conference call or presentation 15-Jan-19 4:00pm GMT,Thomson Reuters StreetEvents
Feb-12-19,"How Financially Strong Is Advaxis, Inc. (NASDAQ:ADXS)?",Simply Wall St.
Feb-14-19,Advaxis Announces Enrollment of the First Patient in its Phase 1/2 Trial for ADXS-HOT in the Treatment of Non-Small Cell Lung Cancer,Business Wire
Feb-20-19,Advaxis (ADXS) Upgraded to Buy: Here's What You Should Know,Zacks
Mar-11-19,Advaxis Announces Presentations of ADXS-NEO and ADXS-PSA Data at Upcoming American Association for Cancer Research Annual Meeting,Business Wire
Mar-12-19,Advaxis: Fiscal 1Q Earnings Snapshot,Associated Press
Mar-12-19,Advaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline Update,Business Wire
Mar-13-19,These Four Healthcare Stocks Are Making Moves on Wednesday,ACCESSWIRE
Mar-13-19,Seres Therapeutics (MCRB) in Focus: Stock Moves 6.7% Higher,Zacks
Mar-22-19,Has Advaxis (ADXS) Outpaced Other Medical Stocks This Year?,Zacks
Mar-25-19,Top Ranked Momentum Stocks to Buy for March 25th,Zacks
Mar-25-19,Advaxis Granted U.S. Patent Relating to Axalimogene Filolisbac,Business Wire
Mar-27-19,Top Ranked Momentum Stocks to Buy for March 27th,Zacks
Mar-28-19,Advaxis Announces Reverse Stock Split,Business Wire
Mar-28-19,Top Ranked Momentum Stocks to Buy for March 28th,Zacks
Mar-29-19,Preliminary Data from Phase 1 Study Evaluating ADXS-NEO Suggest Rapid Immunogenicity and Clinical Activity,Business Wire
Apr-01-19,"Why Wynn Resorts, Advaxis, and Roku Jumped Today",Motley Fool
Apr-01-19,Why Advaxis Stock Skyrocketed 13.8% Today,Motley Fool
Apr-01-19,Advaxis Shares Surge After Positive Clinical Trial Updates,Benzinga
Apr-01-19,"Reverse Split and New Clinical Data, What's Next for Advaxis?",ACCESSWIRE
Apr-01-19,Biotech News: Why Advaxis Stock Is Soaring Today,InvestorPlace
Apr-02-19,"Advaxis, Inc. Announces Proposed Public Offering of Common Stock",Business Wire
Apr-02-19,Advaxis Up on Positive Early-Stage Immunotherapy Study Data,Zacks
